Delgado SLA, Rojas PSA, Rodríguez BMR

Language: Spanish
References: 6
Page: 454-456
PDF size: 1390.50 Kb.

ABSTRACT

Placenta accreta spectrum disorders are defined by abnormal trophoblastic invasion into the myometrium, with a rising incidence due to the increase in cesarean deliveries. In symptomatic patients with focal accreta and/or persistent placental tissue, hysteroscopic resection has been proposed as a conservative alternative to hysterectomy. First described by Goldberg in 1997 and later reported by Quan in 2002 for retained placental tissue, hysteroscopy allows targeted resection under direct visualization, confirming the absence of a cleavage plane and reducing risks associated with “blind” procedures. This minimally invasive approach offers an innovative fertility-preserving option in selected clinical scenarios.

REFERENCES

1. Sentilhes L, Kayem G, Chandraharan E, Palacios-Jaraquemada J,Jauniaux E; FIGO Placenta Accreta Diagnosis and Management ExpertConsensus Panel. FIGO consensus guidelines on placenta accretaspectrum disorders: conservative management. Int J Gynaecol Obstet. 2018; 140 (3): 291-298.

2. American College of Obstetricians and Gynecologists, Society forMaternal-Fetal Medicine. Obstetric care consensus no. 7: Placentaaccreta spectrum: Placenta accreta spectrum. Obstet Gynecol. 2018;132 (6): e259-e275.

3. Hequet D, Morel O, Soyer P, Gayat E, Malartic C, Barranger E. Delayedhysteroscopic resection of retained tissues and uterine conservationafter conservative treatment for placenta accreta. Aust N Z J ObstetGynaecol. 2013; 53 (6): 580-583.

4. Sundararajan S, Roy S, Polanski LT. The accuracy of ultrasound scanin diagnosing retained products of conception: a systematic reviewand meta-analysis. Am J Obstet Gynecol. 2024; 230 (5): 512-531.e3. doi: 10.1016/j.ajog.2023.11.1243.

5. Mazzon I, Favilli A, Grasso M, Horvath S, Gerli S. Is the cold loophysteroscopic technique a myometrial sparing treatment for placentaaccreta residuals in a puerperal uterus? J Matern Fetal Neonatal Med.2016; 29 (10): 1613-1616.

6. Namazi G, Haber HR, Tavcar J, Clark NV. Minimally invasivemanagement of retained products of conception and the adherentplacenta. Curr Opin Obstet Gynecol. 2021; 33 (4): 311-316.